Predictive Models for Treatment of Neutropenia Summary: Every biological system can be represented by a mathematical model. The fidelity of such a model depends on the assumed form of the model, as well as the quality and quantity of data used in its determination. In this study, patients undergoing Granulocyte-Colony Stimulating Factor (G-CSF) treatment to prevent neutropenia (dangerously low neutrophil count) are viewed as systems with G-CSF as input (I) and absolute neutrophil count (ANC) as output (O). Several treatments for cancer (radiation, chemotherapy), as well as cancer itself, can cause neutropenia. Control of neutrophil count is critical to the cancer therapy process, as neutrophils comprise a primary defense mechanism for the body. Therefore, a predictive model for ANC is very useful for treatment, for two reasons: (1) neutropenia can force the suspension of radiation treatment or chemotherapy, and a predictive model can eliminate that risk; and (2) G-CSF treatment is costly, so it should be administered as precisely (sparingly) as possible. Given I/O behaviour over time, the goal is to fit a mathematical model to those data. Linear models were extracted from I/O data using a number of parameter estimation strategies. Specifically, two conventional on-line methods (minimization of mean square error and long range predictive identification) and two new off-line methods (optimization of a cost function with constant time delay and optimization of a cost function with a fixed pattern filter) were used. The quality of the resulting identified models was judged on the basis of the value of the root mean square estimation error and the quality of the model's predictive capability over a future horizon of interest, resulting in the following observations and conclusions:
Information supplied by: Jim Taylor Last update: 1999 October 20 Email requests for further information to: Jim Taylor (jtaylor@unb.ca) |